evaluate the pharmaceuticals company wegovy on glp-1 drugs for diabetes What Are Side Effects of and Ozempic? Wegovy® Pill (Oral GLP-1) Prescribed
Description
The monoclonal antibody drug Volagidemab is currently the only GCGR-targeting antagonist in clinical development
It may also be beneficial to consider individuals at high risk for prodromal PD
The study design incorporated two reference groups (diabetes and overweight/obese), to reduce the influence of potential confounding variables
But emerging research suggests these medicines also offer healthspanextending benefits for people without obesity or diabetes
